Last reviewed · How we verify
DTaP vaccine and IPV vaccine
DTaP vaccine and IPV vaccine is a vaccine Biologic drug developed by Boryung Pharmaceutical Co., Ltd. It is currently in Phase 3 development for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children. Also known as: Boryung DTaP Vaccine Inj. (Prefilled syringe), IPVAX INJ. PREFILLED SYRINGE INJ.
This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, and poliovirus.
This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, and poliovirus. Used for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children.
At a glance
| Generic name | DTaP vaccine and IPV vaccine |
|---|---|
| Also known as | Boryung DTaP Vaccine Inj. (Prefilled syringe), IPVAX INJ. PREFILLED SYRINGE INJ |
| Sponsor | Boryung Pharmaceutical Co., Ltd |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
DTaP vaccine contains inactivated toxins from diphtheria and tetanus bacteria plus acellular pertussis antigens, while IPV contains inactivated poliovirus particles. Together, they prime both humoral and cell-mediated immune responses to prevent these four infectious diseases. The combination formulation simplifies immunization schedules by delivering multiple vaccines in a single injection.
Approved indications
- Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children
Common side effects
- Injection site pain, redness, or swelling
- Fever
- Fussiness or irritability
- Drowsiness
- Loss of appetite
Key clinical trials
- Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations (PHASE4)
- Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants (PHASE1, PHASE2)
- Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers (PHASE2, PHASE3)
- Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents (PHASE3)
- Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DTaP vaccine and IPV vaccine CI brief — competitive landscape report
- DTaP vaccine and IPV vaccine updates RSS · CI watch RSS
- Boryung Pharmaceutical Co., Ltd portfolio CI
Frequently asked questions about DTaP vaccine and IPV vaccine
What is DTaP vaccine and IPV vaccine?
How does DTaP vaccine and IPV vaccine work?
What is DTaP vaccine and IPV vaccine used for?
Who makes DTaP vaccine and IPV vaccine?
Is DTaP vaccine and IPV vaccine also known as anything else?
What drug class is DTaP vaccine and IPV vaccine in?
What development phase is DTaP vaccine and IPV vaccine in?
What are the side effects of DTaP vaccine and IPV vaccine?
Related
- Drug class: All vaccine drugs
- Manufacturer: Boryung Pharmaceutical Co., Ltd — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children
- Also known as: Boryung DTaP Vaccine Inj. (Prefilled syringe), IPVAX INJ. PREFILLED SYRINGE INJ